| Product Information |
|
| Registration Number |
BR-1385
|
| Generic Name |
Bevacizumab
|
| Brand Name |
Avamab
|
| Dosage Strength |
400 mg/16 mL (25 mg/mL)
|
| Dosage Form |
Concentrate for Solution for Infusion (IV)
|
| Classification |
Prescription Drug (Rx)
|
| Packaging |
20 mL (Net content: 16 mL) Type I borosilicate colorless glass vial with chlorobutyl rubber stopper, crimped with aluminum seal fitted with plastic flip-off cap (Box of l's)
|
| Pharmacologic Category |
VEGF/VEGFR (Vascular Endothelial Growth Factor) Inhibitors
|
| Manufacturer |
Sinergium Biotech S.A.
|
| Country of Origin |
Argentine Republic
|
| Trader |
Mabxience Research S.L.
|
| Importer |
Globo Asiatico Enterprises, Inc.
|
| Distributor |
Globo Asiatico Enterprises, Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
02 February 2022
|
| Expiry Date |
02 February 2027
|